Align Technology (NASDAQ:ALGN) Reports Q2 CY2026 In Line With Expectations But Quarterly Revenue Guidance Slightly Misses Expectations

{
  "signal_id": "0a7c54c9-e91d-c5a3-07b2-d956a52da610",
  "signal_type": "news",
  "signal_subtype": "has_earnings",
  "detected_at": "2026-07-29T21:31:57+00:00",
  "company": {
    "name": "Align Technology",
    "domain": "aligntech.com"
  },
  "data": {
    "url": "https://stockstory.org/us/stocks/nasdaq/algn/news/earnings/align-technology-nasdaqalgn-reports-q2-cy2026-in-line-with-expectations-but-quarterly-revenue-guidance-slightly-misses-expectations",
    "title": "Align Technology (NASDAQ:ALGN) Reports Q2 CY2026 In Line With Expectations But Quarterly Revenue Guidance Slightly Misses Expectations - StockStory",
    "excerpt": "Dental technology company Align Technology (NASDAQ:ALGN) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 4.3% year on year to $1.06 billion. On the other hand, next quarter’s revenue guidance of $1.01 billion was less impressive, coming in 1.3% below analysts’ estimates. Its non-GAAP profit of $2.64 per share was 1.7% above analysts’ consensus estimates. Is now the time to buy Align Technology? Find out in our full research report . Pioneering an alternative to traditional metal braces with nearly invisible plastic aligners, Align Technology (NASDAQ:ALGN) designs and manufactures Invisalign clear aligners, iTero intraoral scanners, and dental CAD/CAM software for orthodontic and restorative treatments. A company’s long-term sales performance can indicate its overall quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Over the last five years, Align Technology grew its sales at a tepid 3.6% compounded annual growth rate. This fell short of our benchmark for the healthcare sector and is a tough starting point for our analysis. Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. Align Technology’s recent performance shows its demand has slowed as its annualized revenue growth of 2.5% over the last two years was below its...",
    "summary": "Align Technology reported a non-GAAP profit of $2.64 per share for Q2 CY2026.",
    "planning": false,
    "image_url": "https://stockstory.org/stockstory/company-image/ALGN",
    "confidence": 0.95,
    "published_at": "2026-07-29T21:31:57Z",
    "article_sentence": "Its non-GAAP profit of $2.64 per share was 1.7% above analysts’ consensus estimates.",
    "amount_normalized": 2
  }
}

curl https://signals.autobound.ai/v1/signals/0a7c54c9-e91d-c5a3-07b2-d956a52da610 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"aligntech.com","limit":20}'